Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Innocan Pharma Corp C.INNO

Alternate Symbol(s):  INNPF

Healthcare
Innocan Pharma Corporation is an Israel-based company active in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, the Company aims to provide a safe, non-opioid chronic pain management solutions for both animals and humans. To achieve this aim, the Company developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management. In the wellness sector, the Company develops and markets a wide portfolio of high-performance self-care and beauty products to promote a healthier lifestyle. Under this segment Innocan established a Joint Venture (BI Sky Global Ltd.) that focused on advanced, targeted online sales.


CSE:INNO - Post by User

Innocan Pharma Corp > Innocan Pharma: Retail investors bought over 40% in 2021
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(5)
•••
Post by Stockwonderon Jul 06, 2021 8:30am
174 Views
Post# 33497990

Innocan Pharma: Retail investors bought over 40% in 2021

Innocan Pharma: Retail investors bought over 40% in 2021Data from Frankfurt & Tradegate Stock Exchange. Perhaps those were investors from Poland, too. It seems that INNO is planning to spread in Europe first. 

Not only Polyflame and Health Investment are interessted in Sales Progress all over Europe...this could be gettin huge in near future. IMHO.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities